wegovy mash - Search News

Order byBest matchMost fresh

News

Wegovy, Novo Nordisk and FDA

Pharmaceutical Technology · 21m

Wegovy becomes first GLP-1RA to gain FDA MASH approval

Novo Nordisk's Wegovy has received accelerated approval for use in patients with metabolic dysfunction-associated steatohepatitis (MASH).

Continue reading

· 2d · on MSN

Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH

Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease

1hon MSN

Novo Nordisk shares pop 5% after Wegovy receives U.S. approval for liver disease

The firm was granted U.S. approval for the treatment of metabolic dysfunction-associated steatohepatitis in adults with ...

2d

Novo Nordisk’s Wegovy gets accelerated US approval for serious liver condition

Wegovy is the first GLP-1 treatment approved for MASH. Read more at straitstimes.com. Read more at straitstimes.com.

2d

Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a new indication for Wegovy® ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results